Status:
COMPLETED
Study of Emotion and Cognition Abilities of Children With PWS and Proposition of an Innovative Remediation
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Prader-Willi Syndrome
Eligibility:
All Genders
9-15 years
Phase:
NA
Brief Summary
The present project project is divided in two parts. The primary aim of the part 1 of this study is to evaluate emotional control abilities of children with Prader-Willi syndrome (PWS) aged from 9 to ...
Detailed Description
Prader-Willi Syndrome (PWS) is a rare genetic disorder involving a variety of clinical, behavioral and cognitive symptoms. 83 to 97% of patients have episodes of temper tantrum, associated with an imp...
Eligibility Criteria
Inclusion
- Age from 9 to 15 years old
- Prader-Willi syndrome with identified genotype.
- No psychiatric disorder neither PWS.
- Severe global symptomatology attested by a CGI-S score
Exclusion
- Identified psychiatric or behavioral disorders
- Severe visual or hearing impairment.
- Sleep apnea syndrome treated with non-invasive ventilation,
- Epileptic seizures
- Cardiac disorders.
Key Trial Info
Start Date :
September 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 27 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04526379
Start Date
September 7 2020
End Date
April 27 2022
Last Update
August 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Toulouse, France